***** Coming up on May 11th: BDI’s Social Communications & Healthcare event – half day session in NYC with Case Studies and Roundtables (I’ll be leading one of the roundtables). Top speakers …
Impactiviti Daily 031510
***** TODAY’S NEWS TriCor = placebo? Not good news for Abbott - A popular triglyceride-lowering drug that has been taken by millions of Americans failed to prevent heart disease in a big federal …
Impactiviti Daily 030810
***** TODAY’S NEWS New experimental RA/Lupus drug suspended after patient deaths - Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending rheumatoid arthritis …
Today’s Top Three in Pharma 033109
When placebos outperform CNS drugs - an interesting article on Seeking Alpha. Afinitor - new cancer blockbuster for Novartis? - Novartis AG’s cancer pill Afinitor, approved yesterday by U.S. …
Today’s Top Three in Pharma 021609
Takeda gets approval for Uloric - Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced today that the United States Food and …
Pharma News this week
Glaxo: more big cuts, and the U.S. HQ needle pointing south - GlaxoSmithKline (GSK) announced that it will reduce its sales personnel by 12% to 7,500 down from 8,500. The company will slash 1,800 jobs …